149 related articles for article (PubMed ID: 34440590)
1. Establishment of an Intradermal Ear Injection Model of IL-17A and IL-36γ as a Tool to Investigate the Psoriatic Cytokine Network.
Kluwig D; Huth S; Abdallah AT; Pfaff CM; Fietkau K; Huth L; Marquardt Y; Baron JM; Lüscher B
Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440590
[TBL] [Abstract][Full Text] [Related]
2. IL-17A synergistically enhances TLR3-mediated IL-36γ production by keratinocytes: A potential role in injury-amplified psoriatic inflammation.
Liu S; Wu F; Wu Z; Li Y; Zhang S; Yu N
Exp Dermatol; 2019 Mar; 28(3):233-239. PubMed ID: 30614571
[TBL] [Abstract][Full Text] [Related]
3. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
[TBL] [Abstract][Full Text] [Related]
4. IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.
Bridgewood C; Fearnley GW; Berekmeri A; Laws P; Macleod T; Ponnambalam S; Stacey M; Graham A; Wittmann M
Front Immunol; 2018; 9():200. PubMed ID: 29535706
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
[TBL] [Abstract][Full Text] [Related]
6. Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating IκBζ.
Tu J; Yin Z; Guo J; He F; Long F; Yin Z
Int Immunopharmacol; 2020 Feb; 79():106045. PubMed ID: 31863918
[TBL] [Abstract][Full Text] [Related]
7. Persistent expression of interleukin-17 and downstream effector cytokines in recalcitrant psoriatic lesions after ustekinumab treatment.
Kim BR; Kim M; Yang S; Choi CW; Lee KS; Youn SW
J Dermatol; 2021 Jun; 48(6):876-882. PubMed ID: 33860544
[TBL] [Abstract][Full Text] [Related]
8. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A.
Rizzo HL; Kagami S; Phillips KG; Kurtz SE; Jacques SL; Blauvelt A
J Immunol; 2011 Feb; 186(3):1495-502. PubMed ID: 21172868
[TBL] [Abstract][Full Text] [Related]
9. The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function.
Pfaff CM; Marquardt Y; Fietkau K; Baron JM; Lüscher B
Sci Rep; 2017 Nov; 7(1):15631. PubMed ID: 29142248
[TBL] [Abstract][Full Text] [Related]
10. IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis.
Wang W; Yu X; Wu C; Jin H
Int J Med Sci; 2017; 14(10):1002-1007. PubMed ID: 28924372
[TBL] [Abstract][Full Text] [Related]
11. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
[TBL] [Abstract][Full Text] [Related]
12. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin G cleaves and activates IL-36γ and promotes the inflammation of psoriasis.
Guo J; Tu J; Hu Y; Song G; Yin Z
Drug Des Devel Ther; 2019; 13():581-588. PubMed ID: 30804664
[TBL] [Abstract][Full Text] [Related]
14. IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions.
D'Erme AM; Wilsmann-Theis D; Wagenpfeil J; Hölzel M; Ferring-Schmitt S; Sternberg S; Wittmann M; Peters B; Bosio A; Bieber T; Wenzel J
J Invest Dermatol; 2015 Apr; 135(4):1025-1032. PubMed ID: 25525775
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the cytokine TWEAK in the pathogenesis of psoriasis vulgaris, pustular psoriasis, and erythrodermic psoriasis.
Wang H; Wang S; Li L; Wang X; Liu C; Lu M; Xia Y; Liu Y
Cytokine; 2021 Feb; 138():155391. PubMed ID: 33302223
[TBL] [Abstract][Full Text] [Related]
16. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
Otobe S; Sugaya M; Nakajima R; Oka T; Takahashi N; Kabasawa M; Miyagaki T; Asano Y; Sato S
J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ.
Ainscough JS; Macleod T; McGonagle D; Brakefield R; Baron JM; Alase A; Wittmann M; Stacey M
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2748-E2757. PubMed ID: 28289191
[TBL] [Abstract][Full Text] [Related]
18. MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation.
Monin L; Gudjonsson JE; Childs EE; Amatya N; Xing X; Verma AH; Coleman BM; Garg AV; Killeen M; Mathers A; Ward NL; Gaffen SL
J Immunol; 2017 Jan; 198(2):767-775. PubMed ID: 27920272
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus Inhibits TNF-α/IL-17A-Produced pro-Inflammatory Effect on Human Keratinocytes by Regulating IκBζ.
Hu Y; Guo J; Yin L; Tu J; Yin Z
Inflammation; 2020 Apr; 43(2):692-700. PubMed ID: 31838663
[TBL] [Abstract][Full Text] [Related]
20. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
